scholarly journals 16. Genetic Diagnosis and Therapeutic Strategy for Charcot-Marie-Tooth Disease

2016 ◽  
Vol 105 (9) ◽  
pp. 1855-1863
Author(s):  
Masanori Nakagawa
2013 ◽  
Vol 210 (4) ◽  
pp. 821-838 ◽  
Author(s):  
Maurizio D’Antonio ◽  
Nicolò Musner ◽  
Cristina Scapin ◽  
Daniela Ungaro ◽  
Ubaldo Del Carro ◽  
...  

P0 glycoprotein is an abundant product of terminal differentiation in myelinating Schwann cells. The mutant P0S63del causes Charcot-Marie-Tooth 1B neuropathy in humans, and a very similar demyelinating neuropathy in transgenic mice. P0S63del is retained in the endoplasmic reticulum of Schwann cells, where it promotes unfolded protein stress and elicits an unfolded protein response (UPR) associated with translational attenuation. Ablation of Chop, a UPR mediator, from S63del mice completely rescues their motor deficit and reduces active demyelination by half. Here, we show that Gadd34 is a detrimental effector of CHOP that reactivates translation too aggressively in myelinating Schwann cells. Genetic or pharmacological limitation of Gadd34 function moderates translational reactivation, improves myelination in S63del nerves, and reduces accumulation of P0S63del in the ER. Resetting translational homeostasis may provide a therapeutic strategy in tissues impaired by misfolded proteins that are synthesized during terminal differentiation.


2015 ◽  
Vol 2015 ◽  
pp. 1-2 ◽  
Author(s):  
Helle Høyer ◽  
Geir J. Braathen ◽  
Øyvind L. Busk ◽  
Øystein L. Holla ◽  
Marit Svendsen ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Helle Høyer ◽  
Geir J. Braathen ◽  
Anette K. Eek ◽  
Gry B. N. Nordang ◽  
Camilla F. Skjelbred ◽  
...  

Copy number variations (CNVs) are important in relation to diversity and evolution but can sometimes cause disease. The most common genetic cause of the inherited peripheral neuropathy Charcot-Marie-Tooth disease is thePMP22duplication; otherwise, CNVs have been considered rare. We investigated CNVs in a population-based sample of Charcot-Marie-Tooth (CMT) families. The 81 CMT families had previously been screened for thePMP22duplication and point mutations in 51 peripheral neuropathy genes, and a genetic cause was identified in 37 CMT families (46%). Index patients from the 44 CMT families with an unknown genetic diagnosis were analysed by whole-genome array comparative genomic hybridization to investigate the entire genome for larger CNVs and multiplex ligation-dependent probe amplification to detect smaller intragenomic CNVs inMFN2andMPZ. One patient had the pathogenicPMP22duplication not detected by previous methods. Three patients had potentially pathogenic CNVs in theCNTNAP2,LAMA2, orSEMA5A, that is, genes related to neuromuscular or neurodevelopmental disease. Genotype and phenotype correlation indicated likely pathogenicity for theLAMA2CNV, whereas theCNTNAP2andSEMA5ACNVs remained potentially pathogenic. Except thePMP22duplication, disease causing CNVs are rare but may cause CMT in about 1% (95% CI 0–7%) of the Norwegian CMT families.


Sign in / Sign up

Export Citation Format

Share Document